Both in Pharmaceuticals
Avalyn Pharma vs Omeros
Over the past year AVLN returned −20.6% and OMER returned −6.6%; their daily moves had a correlation of 0.27.
AVLN −20.6% OMER −6.6%Growth of $1, one year, split-adjusted
| Metric | AVLN | OMER |
|---|---|---|
| Price | $26.67 | $17.07 |
| Market cap | $1.18B | $1.24B |
| Today | −2.91% | −6.11% |
| 1 month | +4.5% | −9.0% |
| 6 months | — | +16.6% |
| Year to date | — | −0.6% |
| 1 year | — | +153.6% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | 97.2% |
| Net margin | — | 46.4% |
| P/E (TTM) | — | 9.9× |
| Price / sales | — | 32.2× |
| Net cash | $337.6M | $58.7M |
| Dividend yield | — | — |
| Volatility (60d) | — | 77.9% |
| Short % of float | 11.6% | 17.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).